Compare HURA & CODA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HURA | CODA |
|---|---|---|
| Founded | 2009 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Machinery/Components |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 131.8M | 120.0M |
| IPO Year | N/A | N/A |
| Metric | HURA | CODA |
|---|---|---|
| Price | $0.45 | $11.29 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 191.0K |
| Earning Date | 03-31-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.90 |
| EPS | N/A | ★ 0.37 |
| Revenue | N/A | ★ $26,563,126.00 |
| Revenue This Year | N/A | $20.90 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $30.46 |
| Revenue Growth | N/A | ★ 30.75 |
| 52 Week Low | $0.41 | $5.76 |
| 52 Week High | $5.03 | $12.22 |
| Indicator | HURA | CODA |
|---|---|---|
| Relative Strength Index (RSI) | 17.62 | 59.09 |
| Support Level | $0.41 | $9.86 |
| Resistance Level | $0.75 | $11.47 |
| Average True Range (ATR) | 0.07 | 0.74 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 12.57 | 63.39 |
TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.
Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company operates in three distinct business segments: the Marine Technology business, Acoustic Sensors and Material Business and the Defense Engineering Services Business. Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.